Molecular Therapy - Nucleic Acids
Volume 17, 6 September 2019, Pages 829-839
Original ArticleCRISPR-Cas9-Mediated Genome Editing Increases Lifespan and Improves Motor Deficits in a Huntington’s Disease Mouse Model
Under a Creative Commons license
open access
Keywords
CRISPR-Cas9
Huntington’s disease
AAV
gene therapy
genome editing
Cited by (0)
© 2019 The Authors.